Where does Hangzhou Weiying Medical Technology Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Hangzhou Weiying Medical Technology Co., Ltd. ranks #35,629 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Hangzhou Weiying Medical Technology Co., Ltd. hold?

Hangzhou Weiying Medical Technology Co., Ltd. holds 7 US utility patents granted between 2020 and 2024, spanning 8 technology areas.

What is Hangzhou Weiying Medical Technology Co., Ltd.'s Innovation Score?

Hangzhou Weiying Medical Technology Co., Ltd. has an Innovation Score of 35.8 out of 100 (top 48% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Hangzhou Weiying Medical Technology Co., Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Hangzhou Weiying Medical Technology Co., Ltd..

What does claim depth mean for Hangzhou Weiying Medical Technology Co., Ltd.'s patents?

Hangzhou Weiying Medical Technology Co., Ltd.'s patents average 16.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Hangzhou Weiying Medical Technology Co., Ltd.

Q: What technology areas does Hangzhou Weiying Medical Technology Co., Ltd. focus on?

Hangzhou Weiying Medical Technology Co., Ltd.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 4 patents. Grants appear in 8 CPC subclasses total.

Q: How is the Hangzhou Weiying Medical Technology Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hangzhou ranks #35,629 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#35,629
of 49,997 US assignees by volume: Top 48%
by Innovation Score (35.8/100): 16.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R35629 · Foreign Corporation #35,629 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #35,629/49,997
PHOTO-FINISH Hamlin (SUZHOU)
CPC-NARROW A61F · 8 areas
INNOV-THIN 35.8/100
CLAIMS-RICH 16.3 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Hamlin Electronics (SUZHOU) Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Hangzhou Weiying… · this assignee

36
3D Lighting… · lowest

7

What this shows Hangzhou's Innovation Score is 35.8/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Hangzhou's grants concentrate

Hangzhou Weiying Medical Technology Co., Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 57.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2022. By volume, Hangzhou sits between Hamlin Electronics (SUZHOU) Ltd. and Happe Spine, LLC.

Hangzhou's three-year grant acceleration

Hangzhou Weiying Medical Technology Co., Ltd. shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hamlin (Suzhou)

7
Hands

7
Hangzhou Converd

7
Hangzhou Sizone T…

7
Hansa Biopharma AB

7
Hanseo University…

7
Hanwha Advanced M…

7
Happe Spine

7
Hangzhou Weiying… ◀

7

What this shows Hangzhou holds 7 patents at rank #35,609, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Hangzhou

By rank, the assignees closest to #35,609 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Hangzhou's primary technology class.

Hangzhou's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Hangzhou Weiying Medical Technology Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	3	42.9%
2022	1	14.3%
2023	1	14.3%
2024	2	28.6%

Which technologies does Hangzhou Weiying Medical Technology Co., Ltd. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

A61B - DIAGNOSIS; SURGERY; Identification 3

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 2

G06T - Image Data Processing OR Generation, IN General 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

G06V - Image OR Video Recognition OR Understanding 1

G06F - Electric Digital Data Processing 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#35,629

of 49,997 tracked assignees

Innovation Score

35.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Hangzhou Weiying Medical Technology Co., Ltd.'s patent record in context - here's where to go next.

Hangzhou Weiying Medical Technology Co., Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 57.1% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #35,629 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Hangzhou Weiying Medical Technology Co., Ltd. against Hamlin Electronics (SUZHOU) Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.